Our comment to FDA about its use of the Pharmacy Compounding Advisory Committee (PCAC) was covered...
San Diego news radio focuses on GLP-1 price
San Diego’s KOGO has a short news piece on tirzepatide coming out of shortage, and its focus is on the price. It’s actually based on a CNN story, but we’re not quibbling — it quoted CEO Scott Brunner: “[T]he fact is, a lot of patients were able to afford the compounded versions of tirzepatide, and they’re likely not going to be able to afford the FDA-approved drug.”
